Literature DB >> 20217603

LHRH-targeted nanoparticles for cancer therapeutics.

Tamara Minko1, Mahesh L Patil, Min Zhang, Jayant J Khandare, Maha Saad, Pooja Chandna, Oleh Taratula.   

Abstract

Synthesis and evaluation of a novel cancer cell's receptor-targeted internally quaternized and surface neutral poly(amidoamine) (PAMAM) generation four dendrimer as well as PAMAM-paclitaxel conjugate are described. The advantages of developed nanocarriers include but are not limited to (1) internal cationic charges for the complexation with small interfering RNA or antisense oligonucleotides and their protection from the degradation in systemic circulation; (2) neutral-modified surface for low cytotoxicity of empty unloaded dendrimers; (3) efficient internalization by cancer cells; and (4) preferential accumulation in the tumor and the prevention of adverse side effects of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217603     DOI: 10.1007/978-1-60761-609-2_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Precision targeted therapy of ovarian cancer.

Authors:  Justin Sapiezynski; Oleh Taratula; Lorna Rodriguez-Rodriguez; Tamara Minko
Journal:  J Control Release       Date:  2016-10-14       Impact factor: 9.776

2.  LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer.

Authors:  Natalia V Nukolova; Hardeep S Oberoi; Yi Zhao; Vladimir P Chekhonin; Alexander V Kabanov; Tatiana K Bronich
Journal:  Mol Pharm       Date:  2013-08-30       Impact factor: 4.939

3.  Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.

Authors:  Larisa Sheihet; Olga B Garbuzenko; Jared Bushman; Murugesan K Gounder; Tamara Minko; Joachim Kohn
Journal:  Eur J Pharm Sci       Date:  2011-12-03       Impact factor: 4.384

4.  Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.

Authors:  Vatsal Shah; Oleh Taratula; Olga B Garbuzenko; Mahesh L Patil; Ronak Savla; Min Zhang; Tamara Minko
Journal:  Curr Drug Discov Technol       Date:  2013-03

5.  Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.

Authors:  Mahesh L Patil; Min Zhang; Tamara Minko
Journal:  ACS Nano       Date:  2011-02-15       Impact factor: 15.881

6.  Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.

Authors:  Azade Taheri; Rassoul Dinarvand; Fatemeh Atyabi; Fatemeh Ahadi; Farank Salman Nouri; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Atefeh Taheri Borougeni; Pooria Mansoori
Journal:  Int J Mol Sci       Date:  2011-07-15       Impact factor: 5.923

7.  Luteinizing hormone-releasing hormone targeted poly(methyl vinyl ether maleic acid) nanoparticles for doxorubicin delivery to MCF-7 breast cancer cells.

Authors:  Jaleh Varshosaz; Ali Jahanian-Najafabadi; Jila Ghazzavi
Journal:  IET Nanobiotechnol       Date:  2016-08       Impact factor: 1.847

8.  Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs.

Authors:  N A Nikitenko; V S Prassolov
Journal:  Acta Naturae       Date:  2013-07       Impact factor: 1.845

9.  Dendrimers for siRNA Delivery.

Authors:  Swati Biswas; Vladimir P Torchilin
Journal:  Pharmaceuticals (Basel)       Date:  2013-02-04

10.  Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.

Authors:  Ronak Savla; Olga B Garbuzenko; Suzie Chen; Lorna Rodriguez-Rodriguez; Tamara Minko
Journal:  Pharm Res       Date:  2014-06-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.